Global Next-Generation Sequencing (NGS) in Cancer Research Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Global Next-Generation Sequencing (NGS) in Cancer Research Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Analysis of the Next Generation Sequencing (NGS) in Cancer Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Next-Generation Sequencing (NGS) in Cancer Research market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Next-Generation Sequencing (NGS) in Cancer Research market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Next-Generation Sequencing (NGS) in Cancer Research market. The report focuses on well-known providers in the global Next-Generation Sequencing (NGS) in Cancer Research industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Next-Generation Sequencing (NGS) in Cancer Research Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Next-Generation Sequencing (NGS) in Cancer Research market covered in Chapter 4:
Pacific Biosciences
BCl(Beijing Cenomies lnstitute)
Cenomatix Software CmbH
Life Sciences (Roche)
Thermo Fischer Scientific
Next-Generation Sequencing (NGS)
GATC Biotech AG
Macrogen Ilnc
Qiagen N.V
DNASTAR Inc.
Partek Inc.
Biomatters Ltd
Pacific Biosciences
Illumina Incorporated
Knome lnc.
Agilent Technologies lnc
PerkinElmer
In Chapter 11 and 13.3, on the basis of types, the Next-Generation Sequencing (NGS) in Cancer Research market from 2016 to 2027 is primarily split into:
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Others
In Chapter 12 and 13.4, on the basis of applications, the Next-Generation Sequencing (NGS) in Cancer Research market from 2016 to 2027 covers:
Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Next-Generation Sequencing (NGS) in Cancer Research Market Share by Type (2021-2027)
1.5.2 Sequencing by Synthesis
1.5.3 Ion Semiconductor Sequencing
1.5.4 Single-molecule Real-time Sequencing
1.5.5 Nanopore Sequencing
1.5.6 Others
1.6 Market by Application
1.6.1 Global Next-Generation Sequencing (NGS) in Cancer Research Market Share by Application (2021-2027)
1.6.2 Academic Institutes & Research Centers
1.6.3 Hospitals & Clinics
1.6.4 Pharmaceutical & Biotechnology Companies
1.6.5 Others
1.7 Next-Generation Sequencing (NGS) in Cancer Research Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Next-Generation Sequencing (NGS) in Cancer Research Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Next-Generation Sequencing (NGS) in Cancer Research Market
3.1 Value Chain Status
3.2 Next-Generation Sequencing (NGS) in Cancer Research Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Next-Generation Sequencing (NGS) in Cancer Research
3.2.3 Labor Cost of Next-Generation Sequencing (NGS) in Cancer Research
3.2.3.1 Labor Cost of Next-Generation Sequencing (NGS) in Cancer Research Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Pacific Biosciences
4.1.1 Pacific Biosciences Basic Information
4.1.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.1.3 Pacific Biosciences Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.1.4 Pacific Biosciences Business Overview
4.2 BCl(Beijing Cenomies lnstitute)
4.2.1 BCl(Beijing Cenomies lnstitute) Basic Information
4.2.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.2.3 BCl(Beijing Cenomies lnstitute) Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.2.4 BCl(Beijing Cenomies lnstitute) Business Overview
4.3 Cenomatix Software CmbH
4.3.1 Cenomatix Software CmbH Basic Information
4.3.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.3.3 Cenomatix Software CmbH Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.3.4 Cenomatix Software CmbH Business Overview
4.4 Life Sciences (Roche)
4.4.1 Life Sciences (Roche) Basic Information
4.4.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.4.3 Life Sciences (Roche) Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.4.4 Life Sciences (Roche) Business Overview
4.5 Thermo Fischer Scientific
4.5.1 Thermo Fischer Scientific Basic Information
4.5.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.5.3 Thermo Fischer Scientific Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.5.4 Thermo Fischer Scientific Business Overview
4.6 Next-Generation Sequencing (NGS)
4.6.1 Next-Generation Sequencing (NGS) Basic Information
4.6.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.6.3 Next-Generation Sequencing (NGS) Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.6.4 Next-Generation Sequencing (NGS) Business Overview
4.7 GATC Biotech AG
4.7.1 GATC Biotech AG Basic Information
4.7.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.7.3 GATC Biotech AG Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.7.4 GATC Biotech AG Business Overview
4.8 Macrogen Ilnc
4.8.1 Macrogen Ilnc Basic Information
4.8.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.8.3 Macrogen Ilnc Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.8.4 Macrogen Ilnc Business Overview
4.9 Qiagen N.V
4.9.1 Qiagen N.V Basic Information
4.9.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.9.3 Qiagen N.V Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.9.4 Qiagen N.V Business Overview
4.10 DNASTAR Inc.
4.10.1 DNASTAR Inc. Basic Information
4.10.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.10.3 DNASTAR Inc. Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.10.4 DNASTAR Inc. Business Overview
4.11 Partek Inc.
4.11.1 Partek Inc. Basic Information
4.11.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.11.3 Partek Inc. Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.11.4 Partek Inc. Business Overview
4.12 Biomatters Ltd
4.12.1 Biomatters Ltd Basic Information
4.12.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.12.3 Biomatters Ltd Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.12.4 Biomatters Ltd Business Overview
4.13 Pacific Biosciences
4.13.1 Pacific Biosciences Basic Information
4.13.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.13.3 Pacific Biosciences Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.13.4 Pacific Biosciences Business Overview
4.14 Illumina Incorporated
4.14.1 Illumina Incorporated Basic Information
4.14.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.14.3 Illumina Incorporated Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.14.4 Illumina Incorporated Business Overview
4.15 Knome lnc.
4.15.1 Knome lnc. Basic Information
4.15.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.15.3 Knome lnc. Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.15.4 Knome lnc. Business Overview
4.16 Agilent Technologies lnc
4.16.1 Agilent Technologies lnc Basic Information
4.16.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.16.3 Agilent Technologies lnc Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.16.4 Agilent Technologies lnc Business Overview
4.17 PerkinElmer
4.17.1 PerkinElmer Basic Information
4.17.2 Next-Generation Sequencing (NGS) in Cancer Research Product Profiles, Application and Specification
4.17.3 PerkinElmer Next-Generation Sequencing (NGS) in Cancer Research Market Performance (2016-2021)
4.17.4 PerkinElmer Business Overview
5 Global Next-Generation Sequencing (NGS) in Cancer Research Market Analysis by Regions
5.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Regions
5.1.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales by Regions (2016-2021)
5.1.2 Global Next-Generation Sequencing (NGS) in Cancer Research Revenue by Regions (2016-2021)
5.2 North America Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
5.3 Europe Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
5.6 South America Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
6 North America Next-Generation Sequencing (NGS) in Cancer Research Market Analysis by Countries
6.1 North America Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Countries
6.1.1 North America Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
6.1.2 North America Next-Generation Sequencing (NGS) in Cancer Research Revenue by Countries (2016-2021)
6.1.3 North America Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
6.2 United States Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
6.2.1 United States Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
6.3 Canada Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
6.4 Mexico Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7 Europe Next-Generation Sequencing (NGS) in Cancer Research Market Analysis by Countries
7.1 Europe Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Countries
7.1.1 Europe Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
7.1.2 Europe Next-Generation Sequencing (NGS) in Cancer Research Revenue by Countries (2016-2021)
7.1.3 Europe Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
7.2 Germany Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7.2.1 Germany Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
7.3 UK Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7.3.1 UK Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
7.4 France Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7.4.1 France Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
7.5 Italy Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7.5.1 Italy Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
7.6 Spain Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7.6.1 Spain Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
7.7 Russia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
7.7.1 Russia Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
8 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Market Analysis by Countries
8.1 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
8.2 China Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
8.2.1 China Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
8.3 Japan Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
8.3.1 Japan Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
8.4 South Korea Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
8.4.1 South Korea Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
8.5 Australia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
8.6 India Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
8.6.1 India Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
8.7 Southeast Asia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
9 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Market Analysis by Countries
9.1 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
9.2 Saudi Arabia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
9.3 UAE Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
9.4 Egypt Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
9.5 Nigeria Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
9.6 South Africa Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
10 South America Next-Generation Sequencing (NGS) in Cancer Research Market Analysis by Countries
10.1 South America Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Countries
10.1.1 South America Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
10.1.2 South America Next-Generation Sequencing (NGS) in Cancer Research Revenue by Countries (2016-2021)
10.1.3 South America Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
10.2 Brazil Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
10.2.1 Brazil Next-Generation Sequencing (NGS) in Cancer Research Market Under COVID-19
10.3 Argentina Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
10.4 Columbia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
10.5 Chile Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
11 Global Next-Generation Sequencing (NGS) in Cancer Research Market Segment by Types
11.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales and Market Share by Types (2016-2021)
11.1.2 Global Next-Generation Sequencing (NGS) in Cancer Research Revenue and Market Share by Types (2016-2021)
11.2 Sequencing by Synthesis Sales and Price (2016-2021)
11.3 Ion Semiconductor Sequencing Sales and Price (2016-2021)
11.4 Single-molecule Real-time Sequencing Sales and Price (2016-2021)
11.5 Nanopore Sequencing Sales and Price (2016-2021)
11.6 Others Sales and Price (2016-2021)
12 Global Next-Generation Sequencing (NGS) in Cancer Research Market Segment by Applications
12.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales and Market Share by Applications (2016-2021)
12.1.2 Global Next-Generation Sequencing (NGS) in Cancer Research Revenue and Market Share by Applications (2016-2021)
12.2 Academic Institutes & Research Centers Sales, Revenue and Growth Rate (2016-2021)
12.3 Hospitals & Clinics Sales, Revenue and Growth Rate (2016-2021)
12.4 Pharmaceutical & Biotechnology Companies Sales, Revenue and Growth Rate (2016-2021)
12.5 Others Sales, Revenue and Growth Rate (2016-2021)
13 Next-Generation Sequencing (NGS) in Cancer Research Market Forecast by Regions (2021-2027)
13.1 Global Next-Generation Sequencing (NGS) in Cancer Research Sales, Revenue and Growth Rate (2021-2027)
13.2 Next-Generation Sequencing (NGS) in Cancer Research Market Forecast by Regions (2021-2027)
13.2.1 North America Next-Generation Sequencing (NGS) in Cancer Research Market Forecast (2021-2027)
13.2.2 Europe Next-Generation Sequencing (NGS) in Cancer Research Market Forecast (2021-2027)
13.2.3 Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Market Forecast (2021-2027)
13.2.4 Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Market Forecast (2021-2027)
13.2.5 South America Next-Generation Sequencing (NGS) in Cancer Research Market Forecast (2021-2027)
13.3 Next-Generation Sequencing (NGS) in Cancer Research Market Forecast by Types (2021-2027)
13.4 Next-Generation Sequencing (NGS) in Cancer Research Market Forecast by Applications (2021-2027)
13.5 Next-Generation Sequencing (NGS) in Cancer Research Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Next-Generation Sequencing (NGS) in Cancer Research Market Size Growth Rate by Type (2021-2027)
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Market Share by Type in 2020 & 2026
Figure Sequencing by Synthesis Features
Figure Ion Semiconductor Sequencing Features
Figure Single-molecule Real-time Sequencing Features
Figure Nanopore Sequencing Features
Figure Others Features
Table Global Next-Generation Sequencing (NGS) in Cancer Research Market Size Growth by Application (2021-2027)
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Market Share by Application in 2020 & 2026
Figure Academic Institutes & Research Centers Description
Figure Hospitals & Clinics Description
Figure Pharmaceutical & Biotechnology Companies Description
Figure Others Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Next-Generation Sequencing (NGS) in Cancer Research Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Next-Generation Sequencing (NGS) in Cancer Research
Figure Production Process of Next-Generation Sequencing (NGS) in Cancer Research
Figure Manufacturing Cost Structure of Next-Generation Sequencing (NGS) in Cancer Research
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Pacific Biosciences Profile
Table Pacific Biosciences Production, Value, Price, Gross Margin 2016-2021
Table BCl(Beijing Cenomies lnstitute) Profile
Table BCl(Beijing Cenomies lnstitute) Production, Value, Price, Gross Margin 2016-2021
Table Cenomatix Software CmbH Profile
Table Cenomatix Software CmbH Production, Value, Price, Gross Margin 2016-2021
Table Life Sciences (Roche) Profile
Table Life Sciences (Roche) Production, Value, Price, Gross Margin 2016-2021
Table Thermo Fischer Scientific Profile
Table Thermo Fischer Scientific Production, Value, Price, Gross Margin 2016-2021
Table Next-Generation Sequencing (NGS) Profile
Table Next-Generation Sequencing (NGS) Production, Value, Price, Gross Margin 2016-2021
Table GATC Biotech AG Profile
Table GATC Biotech AG Production, Value, Price, Gross Margin 2016-2021
Table Macrogen Ilnc Profile
Table Macrogen Ilnc Production, Value, Price, Gross Margin 2016-2021
Table Qiagen N.V Profile
Table Qiagen N.V Production, Value, Price, Gross Margin 2016-2021
Table DNASTAR Inc. Profile
Table DNASTAR Inc. Production, Value, Price, Gross Margin 2016-2021
Table Partek Inc. Profile
Table Partek Inc. Production, Value, Price, Gross Margin 2016-2021
Table Biomatters Ltd Profile
Table Biomatters Ltd Production, Value, Price, Gross Margin 2016-2021
Table Pacific Biosciences Profile
Table Pacific Biosciences Production, Value, Price, Gross Margin 2016-2021
Table Illumina Incorporated Profile
Table Illumina Incorporated Production, Value, Price, Gross Margin 2016-2021
Table Knome lnc. Profile
Table Knome lnc. Production, Value, Price, Gross Margin 2016-2021
Table Agilent Technologies lnc Profile
Table Agilent Technologies lnc Production, Value, Price, Gross Margin 2016-2021
Table PerkinElmer Profile
Table PerkinElmer Production, Value, Price, Gross Margin 2016-2021
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) and Growth (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales by Regions (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share by Regions (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) by Regions (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Market Share by Regions (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Market Share by Regions in 2016
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Market Share by Regions in 2020
Figure North America Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Europe Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure South America Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure North America Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) and Growth (2016-2021)
Table North America Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
Table North America Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share by Countries (2016-2021)
Figure North America Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share by Countries in 2016
Figure United States Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Canada Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Mexico Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth (2016-2021)
Figure Europe Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) Growth (2016-2021)
Table Europe Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
Table Europe Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share by Countries (2016-2021)
Figure Germany Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure UK Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure France Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Italy Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Spain Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Russia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
Table Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share by Countries (2016-2021)
Figure China Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Japan Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure South Korea Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Australia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure India Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Southeast Asia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales by Countries (2016-2021)
Table Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure UAE Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Egypt Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Nigeria Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure South Africa Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure South America Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) and Growth (2016-2021)
Figure Brazil Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Argentina Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Columbia Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Figure Chile Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales by Types (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) by Types (2016-2021)
Figure Global Sequencing by Synthesis Sales and Growth Rate (2016-2021)
Figure Global Sequencing by Synthesis Price (2016-2021)
Figure Global Ion Semiconductor Sequencing Sales and Growth Rate (2016-2021)
Figure Global Ion Semiconductor Sequencing Price (2016-2021)
Figure Global Single-molecule Real-time Sequencing Sales and Growth Rate (2016-2021)
Figure Global Single-molecule Real-time Sequencing Price (2016-2021)
Figure Global Nanopore Sequencing Sales and Growth Rate (2016-2021)
Figure Global Nanopore Sequencing Price (2016-2021)
Figure Global Others Sales and Growth Rate (2016-2021)
Figure Global Others Price (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales by Applications (2016-2021)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales Share by Applications (2016-2021)
Figure Global Academic Institutes & Research Centers Sales and Growth Rate (2016-2021)
Figure Global Academic Institutes & Research Centers Revenue and Growth Rate (2016-2021)
Figure Global Hospitals & Clinics Sales and Growth Rate (2016-2021)
Figure Global Hospitals & Clinics Revenue and Growth Rate (2016-2021)
Figure Global Pharmaceutical & Biotechnology Companies Sales and Growth Rate (2016-2021)
Figure Global Pharmaceutical & Biotechnology Companies Revenue and Growth Rate (2016-2021)
Figure Global Others Sales and Growth Rate (2016-2021)
Figure Global Others Revenue and Growth Rate (2016-2021)
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Sales and Growth Rate (2021-2027)
Figure Global Next-Generation Sequencing (NGS) in Cancer Research Revenue ($) and Growth Rate (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast by Regions (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast by Regions (2021-2027)
Figure North America Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast (2021-2027)
Figure North America Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast (2021-2027)
Figure Europe Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast (2021-2027)
Figure Europe Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast (2021-2027)
Figure Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast (2021-2027)
Figure Asia-Pacific Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast (2021-2027)
Figure Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast (2021-2027)
Figure Middle East and Africa Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast (2021-2027)
Figure South America Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast (2021-2027)
Figure South America Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales Forecast by Types (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share Forecast by Types (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Market Share Forecast by Types (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Sales Market Share Forecast by Applications (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Forecast by Applications (2021-2027)
Table Global Next-Generation Sequencing (NGS) in Cancer Research Revenue Market Share Forecast by Applications (2021-2027)
Research Methodology:
Next Generation Sequencing (NGS) in Cancer Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|